Investment in life sciences fund
The University is to invest in a venture capital fund focusing on life sciences.
Based in Scotland, the fund - led by US-based firm Rock Spring Ventures - will invest in young companies developing novel approaches to meeting needs in the study and treatment of major diseases.
It will also invest in technologies designed to advance better healthcare delivery, and will provide venture capital to the most promising life science technologies, including those being spun-out from leading universities.
As well as the University of Edinburgh, initial investors in the new fund include the European Investment Fund, Scottish Enterprise, the Strathclyde Pension Fund, Rock Spring Ventures, and the Universities of Glasgow and Aberdeen.
We are particularly excited to be partnering with a unique investor group that includes three of Scotland’s world-class universities to provide the capital needed to realise the full potential of their spin-out companies.
Life sciences work
The University is a leading protagonist in the UK’s life sciences industry, with key strengths including research excellence in regenerative medicine, inflammation and oncology.
In Scotland, Edinburgh BioQuarter - a joint venture between the University, Scottish Enterprise, Alexandria Real Estates Inc and the National Health Service - commercialises world-leading medical research and brings investors, ideas and companies together at the BioQuarter campus on the outskirts of Edinburgh.
Recent businesses spun out by BioQuarter include i2eye Diagnostics Ltd, creators of the world's first visual field analyser for children and vulnerable patient group.
We look forward to working closely with Rock Spring Ventures over the coming years, as well as other venture capital funds, so that more of our excellent life sciences spin-out and start-up companies secure the sort of investment they require to deliver an impact on the international stage. Those companies' achievements will ensure that more of the University's life sciences research transfers from the laboratory towards benefiting society and the Scottish economy.